Search Results - "OMURO, A. M"
-
1
Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma
Published in Neurology (31-05-2011)“…To examine the potential utility of conventional MRI signs in differentiating pseudoprogression (PsP) from early progression (EP). This retrospective study…”
Get full text
Journal Article -
2
Primary CNS lymphoma with intraocular involvement : International PCNSL Collaborative Group Report
Published in Neurology (21-10-2008)“…To describe the demographics, diagnostic details, therapeutic management, and outcome in patients with primary CNS lymphoma (PCNSL) with ocular involvement. A…”
Get full text
Journal Article -
3
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report
Published in Annals of oncology (01-11-2007)“…Background: Primary intraocular lymphoma (PIOL) is an uncommon subset of primary central nervous system lymphoma. Because it is rare and difficult to diagnose,…”
Get full text
Journal Article -
4
Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases : a phase I trial
Published in Journal of neuro-oncology (01-07-2006)“…Temozolomide (TMZ) has shown modest efficacy in the treatment of recurrent brain metastasis (BM). We designed a new regimen utilizing dose-intensified,…”
Get full text
Journal Article -
5
Cognitive functions in primary CNS lymphoma after single or combined modality regimens
Published in Neuro-oncology (Charlottesville, Va.) (01-01-2012)“…The standard treatment for primary CNS lymphoma (PCNSL) involves high-dose methotrexate-based chemotherapy (HD-MTX) alone or in combination with whole brain…”
Get full text
Journal Article -
6
Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma
Published in American journal of neuroradiology : AJNR (01-12-2013)“…Epidermal growth factor receptor amplification is a common molecular event in glioblastomas. The purpose of this study was to examine the potential usefulness…”
Get full text
Journal Article -
7
Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification
Published in Clinical neuroradiology (Munich) (01-06-2015)“…Background and Purpose Molecular and genetic testing is becoming increasingly relevant in GBM. We sought to determine whether dynamic susceptibility contrast…”
Get full text
Journal Article -
8
EGFR tyrosine kinase domain mutations in human gliomas
Published in Neurology (26-04-2005)“…Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor effective in patients with lung cancer with mutations in exons 19 and 21 of…”
Get full text
Journal Article -
9
Methotrexate (MTX) rechallenge for recurrent primary CNS lymphoma (PCNSL)
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
10
-
11
FLAIR, T1 contrast enhancement, MR perfusion, and FDG PET following hypofractionated stereotactic radiotherapy (HFSRT), bevacizumab (BEV), and temozolomide (TMZ) for glioblastoma (GBM)
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
12
Bevacizumab and irinotecan (BI) for gliomatous leptomeningeal disease
Published in Journal of clinical oncology (20-05-2010)“…Abstract only…”
Get full text
Journal Article -
13
What is the place of bevacizumab and irinotecan in the treatment of glioblastoma and other malignant gliomas?
Published in Current opinion in neurology (01-12-2008)“…To critically assess the role of irinotecan (Camptosar, CPT-11) and bevacizumab (Avastin) as a new treatment for glioblastoma and other malignant gliomas…”
Get full text
Journal Article -
14
Magnetic resonance (MR) perfusion imaging to differentiate early progression from pseudoprogression following chemoradiotherapy for glioblastoma (GBM)
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
15
Multicenter phase II trial of temozolomide (TMZ) and rituximab (RIT) for recurrent primary CNS lymphoma (PCNSL): North American Brain Tumor Consortium (NABTC) study 05-01
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
16
Methotrexate (M) area under the curve (AUC) and creatinine clearance (CrCl) as prognostic factors in primary central nervous system lymphoma (PCNSL)
Published in Journal of clinical oncology (20-05-2010)“…Abstract only…”
Get full text
Journal Article -
17
AI-09 PATTERNS OF SALVAGE TREATMENT FOR HIGH GRADE GLIOMA IN THE TEMOZOLOMIDE ERA
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2014)“…PURPOSE: High grade gliomas (HGGs) are aggressive malignancies that recur despite trimodality treatment with surgery, radiation therapy (RT), and temozolomide…”
Get full text
Journal Article -
18
A phase I safety and pharmacokinetic study of XL765 (SAR245409), a novel PI3K/TORC1/TORC2 inhibitor, in combination with temozolomide (TMZ) in patients (pts) with newly diagnosed malignant glioma
Published in Journal of clinical oncology (20-05-2010)“…Abstract only…”
Get full text
Journal Article -
19
A phase II trial of TLN-4601 in patients with glioblastoma multiforme (GBM) at first progression
Published in Journal of clinical oncology (20-05-2010)“…Abstract only…”
Get full text
Journal Article -
20
Multicenter randomized phase II trial of methotrexate (MTX) and temozolomide (TMZ) versus MTX, procarbazine (PCB), vincristine (VINC), and cytarabine (Ara-C) for primary CNS lymphoma (PCNSL) in elderly patients
Published in Journal of clinical oncology (20-05-2010)“…Abstract only…”
Get full text
Journal Article